An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

It is playing catch-up with a rival Lp(a) targeting antisense drug from Novartis and development partner Akcea, called pelacarsen, which is already in a phase 3 trial called HORIZON with major ...

Naturally, the product release cycle keeps on keepin’ on, though actually keeping track of every new gadget and hi-fi release ...

Skarv Shipping expands order to five zero-carbon vessels with Berg Propulsion. Find the latest news from the maritime ...

People with people power-whether being noticed was the motivating factor or not-speak up, step forward and stand out. Gordon B. Hinckley wrote one of my favorite books, Stand for Something.